Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ardelyx, Inc. - Common Stock
(NQ:
ARDX
)
4.910
-0.100 (-2.00%)
Streaming Delayed Price
Updated: 11:47 AM EDT, Aug 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ardelyx, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
20
21
Next >
Nasdaq Up 150 Points; Crude Oil Rises 1%
↗
March 03, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Friday. The Dow traded up 0.59% to 33,197.08 while the NASDAQ rose 1.32% to 11,614.60. The S&P...
Via
Benzinga
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
↗
March 03, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Is Ardelyx (ARDX) Stock Up 25% Today?
↗
March 03, 2023
Ardelyx swung from an earnings loss to a profit and an analyst took notice of the company's progress. Now, ARDX stock is catching a bid.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
↗
March 03, 2023
Via
Benzinga
Why Ardelyx Shares Are Falling
↗
January 19, 2023
Ardelyx Inc (NASDAQ: ARDX) shares are trading lower by 17.03% to $2.67 Thursday morning after the company filed for a mixed shelf offering of up to $250 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 03, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
March 03, 2023
We're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 02, 2023
Via
Benzinga
Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 02, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx Publishes First Environmental, Social and Governance (ESG) Report
February 28, 2023
Report focuses on patient access and affordability, workforce wellness and training, community involvement and sound corporate governance
From
Ardelyx, Inc.
Via
GlobeNewswire
7 Smart Stock Picks for Cautious Investors
↗
February 28, 2023
As market volatility continues, consider playing it safe with these seven high-quality stocks for cautious investors.
Via
InvestorPlace
Ardelyx to Participate at the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 2, 2023
February 23, 2023
Conference call scheduled for 4:30 p.m. Eastern Time
From
Ardelyx, Inc.
Via
GlobeNewswire
7 A-Rated Penny Stocks Worth Betting On
↗
February 19, 2023
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.
Via
InvestorPlace
7 Stocks Under $10 to Buy in February
↗
February 17, 2023
A stock under $10 to buy is more likely to be a growth stock with a longer runway to providing investors with some great returns.
Via
InvestorPlace
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
↗
February 12, 2023
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio.
Via
InvestorPlace
7 A-Rated Stocks to Buy for February 2023
↗
February 07, 2023
Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader.
Via
InvestorPlace
7 A-Rated Stocks to Buy for Less Than $25
↗
January 24, 2023
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market.
Via
InvestorPlace
PPG Industries, Netflix, Ally Financial And Other Big Stocks Moving Higher On Friday
↗
January 20, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
January 19, 2023
Via
Benzinga
5 Under-the-Radar Penny Stocks With 100% Upside Potential
↗
January 16, 2023
Most experts will advise you to steer clear of under the radar penny stocks – and for good reason. However, keep an eye on these.
Via
InvestorPlace
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
↗
December 31, 2022
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like...
Via
Benzinga
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
↗
December 30, 2022
Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday.
Via
Benzinga
Dow Surges 250 Points; Jobless Claims Rise To 225,000
↗
December 29, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday.
Via
Benzinga
The 3 Biggest Opportunities for Penny Stock Investors in 2023
↗
December 21, 2022
Investors should be able to profit from some of the biggest opportunities for penny stock investors identified in this column.
Via
InvestorPlace
Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
↗
December 19, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Health Inc. (NASDAQ: COSM) shares dipped 37.7% to $14.33 in...
Via
Benzinga
FDA Needs More Time For Ardelyx's Appeal To Rejection Of Kidney Disease Candidate
↗
December 19, 2022
Via
Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
↗
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
↗
December 19, 2022
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in...
Via
Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
↗
December 18, 2022
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.
Via
InvestorPlace
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit